BTL Aesthetics today announced that it has received a new designation from the Food & Drug Administration (FDA) for its award-winning, non-invasive fat reduction treatment, BTL Vanquish ME.
Articles by MedicalNews
A good reason to celebrate, say hospital doctors In India, it is estimated that up to 1.5% of the population has a hepatitis C infection, with certain areas in the Punjab, North East and tribal areas considered possible “hepatitis C virus hotspots”.
Silvergate Pharmaceuticals, Inc. (www.silvergatepharma.com), leader in the development and commercialization of innovative and safe medicines for children, has announced that the United States Food and Drug Administration (FDA) approved Qbrelis™ (Lisinopril) Oral Solution, the first and only FDA-approved Lisinopril oral solution.
A team of researchers led by a National Institutes of Health investigator, Teresa Przytycka, Ph.D., has developed a new software tool called AptaTRACE that could be an important advance for drug developers and other scientists who want to identify molecules that bind with high precision to targets of interest.
An updated recommendation from the American Academy of Neurology (AAN) states that catheter-based closure should not be routinely recommended for people who have had a stroke and also have a heart defect called a patent foramen ovale (PFO), a channel between the top two chambers in the heart.
4WEB Medical, the industry leader in 3D printed orthopedic implants, announced today that the company has received 510K clearance from the FDA for its lateral interbody fusion device. The company will market the comprehensive lateral offering under the trade name Lateral Spine Truss System.
Metformin, a medication routinely used by millions of people with type 2 diabetes, may also play an unexpected role in blocking a significant cause of premature birth, according to research findings published July 25.
The majority of American adults taking opioids and other commonly prescribed medications use them in ways that put their health at risk, including potentially dangerous combinations with other drugs, according to a new study from Quest Diagnostics (NYSE: DGX), the world’s leading provider of diagnostic information services.
A new drug developed by scientists at the National Institutes of Health limits the progression of liver fibrosis in mice, a hopeful advance against a condition for which there is no current treatment and that often leads to serious liver disease in people with chronic alcoholism and other common diseases.
The National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, has begun an early-stage clinical trial of an investigational vaccine designed to protect against yellow fever virus.